Phase i study of sunitinib and irinotecan for patients with recurrent malignant glioma

by David A. Reardon, James J. Vredenburgh, April Coan, Annick Desjardins, Katherine B. Peters, Sridharan Gururangan, Sith Sathornsumetee, Jeremy N. Rich, James E. Herndon, Henry S. Friedman
Published 2018

Phase II study of Gleevec plus hydroxyurea in adults with progressive or recurrent low-grade glioma

by David A. Reardon, Annick Desjardins, James J. Vredenburgh, James E. Herndon, April Coan, Sridharan Gururangan, Katherine B. Peters, Roger McLendon, Sith Sathornsumetee, Jeremy N. Rich, Eric S. Lipp, Dorothea Janney, Henry S. Friedman
Published 2018

Phase II trial of bevacizumab and erlotinib in patients with recurrent malignant glioma

by Sith Sathornsumetee, Annick Desjardins, James J. Vredenburgh, Roger E. McLendon, Jennifer Marcello, James E. Herndon, Alyssa Mathe, Marta Hamilton, Jeremy N. Rich, Julie A. Norfleet, Sridharan Gururangan, Henry S. Friedman, David A. Reardon
Published 2018